|
|
|
Volumn 15, Issue 2, 2008, Pages 3954-3966
|
|
Treatment options for metastatic renal cell carcinoma: a review.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA INTERFERON;
ANGIOGENESIS INHIBITOR;
ANTINEOPLASTIC AGENT;
BENZENESULFONIC ACID DERIVATIVE;
BEVACIZUMAB;
DRUG DERIVATIVE;
IMMUNOLOGIC FACTOR;
INDOLE DERIVATIVE;
INTERLEUKIN 2;
MONOCLONAL ANTIBODY;
PYRIDINE DERIVATIVE;
PYRROLE DERIVATIVE;
RAPAMYCIN;
SORAFENIB;
SUNITINIB;
TEMSIROLIMUS;
DRUG EFFECT;
GENETICS;
GRAFT VERSUS HOST REACTION;
HUMAN;
IMMUNOLOGY;
KIDNEY CARCINOMA;
KIDNEY TUMOR;
METASTASIS;
MORTALITY;
MULTIVARIATE ANALYSIS;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
RISK ASSESSMENT;
SIGNAL TRANSDUCTION;
TREATMENT OUTCOME;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
BENZENESULFONATES;
CARCINOMA, RENAL CELL;
GRAFT VS HOST DISEASE;
HUMANS;
IMMUNOLOGIC FACTORS;
INDOLES;
INTERFERON-ALPHA;
INTERLEUKIN-2;
KIDNEY NEOPLASMS;
MULTIVARIATE ANALYSIS;
PROGNOSIS;
PYRIDINES;
PYRROLES;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
RISK ASSESSMENT;
SIGNAL TRANSDUCTION;
SIROLIMUS;
TREATMENT OUTCOME;
|
|
EID: 50349097130
PISSN: 11959479
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (110)
|
|
References (58)
|
